(Q37903940)

25 August 2017

1 reference

title

Tissue-type plasminogen activator-mediated plasminogen activation and contact activation, implications in and beyond haemostasis (English)

1 reference

25 August 2017

1 reference

M F B G Gebbink

1

1 reference

25 August 2017

1 July 2011

1 reference

Journal of Thrombosis and Haemostasis

25 August 2017

1 reference

25 August 2017

9 Suppl 1

1 reference

25 August 2017

174-181

1 reference

Molecular and cellular aspects of protein misfolding and disease

25 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04278.X

Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04278.X

An endothelial storage granule for tissue-type plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04278.X

Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04278.X

Physiological consequences of over- or under-expression of fibrinolytic system components in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04278.X

Novel aspects and new roles for the serine protease plasmin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04278.X

Rapid, specific and active site-catalyzed effect of tissue-plasminogen activator on hippocampus-dependent learning in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04278.X

Tissue plasminogen activator in the amygdala is critical for stress-induced anxiety-like behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04278.X

Role of plasminogen activation in neuronal organization and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04278.X

Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04278.X

Neuronal death in the central nervous system demonstrates a non-fibrin substrate for plasmin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04278.X

Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04278.X

Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04278.X

Neuronal degeneration and a decrease in laminin-like immunoreactivity is associated with elevated tissue-type plasminogen activator in the rat hippocampus after kainic acid injection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04278.X

Plasmin-mediated degradation of laminin gamma-1 is critical for ethanol-induced neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04278.X

Decreased clearance of CNS beta-amyloid in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04278.X

Enhanced clearance of Abeta in brain by sustaining the plasmin proteolysis cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04278.X

The Possible Role of Tissue-Type Plasminogen Activator (tPA) and tPA Blockers in the Pathogenesis and Treatment of Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04278.X

Plasminogen activator activity is inhibited while neuroserpin is up-regulated in the Alzheimer disease brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04278.X

Beta-amyloid (Abeta) causes detachment of N1E-115 neuroblastoma cells by acting as a scaffold for cell-associated plasminogen activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04278.X

Tissue plasminogen activator mediates amyloid-induced neurotoxicity via Erk1/2 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04278.X

A central role for plasminogen in the inflammatory response to biomaterials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04278.X

Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04278.X

Prefibrillar amyloid protein aggregates share common features of cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04278.X

Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04278.X

Quality control of protein folding in extracellular space

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04278.X

Searching for differences between fibrinogen and fibrin that affect the initiation of fibrinolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04278.X

Acceleration of plasminogen activation by tissue plasminogen activator on surface-bound histidine-proline-rich glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04278.X

Tissue-type plasminogen activator is a target of the tumor suppressor gene maspin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04278.X

Actin stimulates plasmin generation by tissue and urokinase-type plasminogen activators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04278.X

Enhanced fibrinolysis by proteolysed coagulation factor Xa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04278.X

beta2-glycoprotein i is a cofactor for tissue plasminogen activator-mediated plasminogen activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04278.X

Glycation induces formation of amyloid cross-beta structure in albumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04278.X

Amyloids--a functional coat for microorganisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04278.X

In vitro stimulation of tissue-type plasminogen activator by Alzheimer amyloid β-peptide analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04278.X

Plasminogen activation is stimulated by prion protein and regulated in a copper-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04278.X

Structural basis of the cofactor function of denatured albumin in plasminogen activation by tissue-type plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04278.X

Stimulating effect on tissue-type plasminogen activator--a new and sensitive indicator of denatured fibrinogen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04278.X

Do antiangiogenic protein fragments have amyloid properties?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04278.X

The interplay between tissue plasminogen activator domains and fibrin structures in the regulation of fibrinolysis: kinetic and microscopic studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04278.X

Identification of fibronectin type I domains as amyloid-binding modules on tissue-type plasminogen activator and three homologs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04278.X

The region 1-11 of Alzheimer amyloid-beta is critical for activation of contact-kinin system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04278.X

Physiological responses to protein aggregates: fibrinolysis, coagulation and inflammation (new roles for old factors).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04278.X

Modifying protein misfolding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04278.X

Physiological consequences of loss of plasminogen activator gene function in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04278.X

Increased plasmin-α2-antiplasmin levels indicate activation of the fibrinolytic system in systemic amyloidoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04278.X

A Role for Protein Misfolding in Immunogenicity of Biopharmaceuticals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04278.X

10.1111/J.1538-7836.2011.04278.X

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference

PubMed ID

21781253